NYMOX PHARMACEUTICAL CORPORATION Increase Decrease In Cash And Cash Equivalents
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Increase Decrease In Cash And Cash Equivalents of $4.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION increase decrease in cash and cash equivalents for the quarter ending 2024-12-31 was $33.00K.
- NYMOX PHARMACEUTICAL CORPORATION increase decrease in cash and cash equivalents for the quarter ending 2023-12-31 was -$6.00K.
- NYMOX PHARMACEUTICAL CORPORATION increase decrease in cash and cash equivalents for the quarter ending 2023-09-30 was -$56.00K.
- NYMOX PHARMACEUTICAL CORPORATION increase decrease in cash and cash equivalents for the quarter ending 2023-06-30 was -$219.00K, a 106.44% decline year-over-year.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 3 month as first filed | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $33.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | $4.00K 20-F · filed 2025-06-03 | |||
| 2024-09-30 | -$29.00K 6-K · filed 2025-01-02 | ||||
| 2023-12-31 | -$6.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$62.00K derived: sum of 2 quarters · filed 2025-06-03 | -$281.00K derived: sum of 3 quarters · filed 2025-06-03 | -$1.33M 20-F · filed 2025-06-03 | |
| 2023-09-30 | -$56.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-01-02 | -$275.00K derived: sum of 2 quarters · filed 2025-01-02 | -$1.33M 6-K · filed 2025-01-02 | -$2.63M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-06-30 | -$219.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | -$1.27M 6-K · filed 2023-08-14 | -$2.57M derived: sum of 3 quarters · filed 2025-06-03 | -$3.94M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-03-31 | -$1.05M 6-K · filed 2023-05-12 | -$2.35M derived: sum of 2 quarters · filed 2025-06-03 | -$3.72M derived: sum of 3 quarters · filed 2025-06-03 | -$321.00K derived: sum of 4 quarters · filed 2025-06-03 | |
| 2022-12-31 | -$1.30M derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$2.67M derived: sum of 2 quarters · filed 2025-06-03 | $731.00K derived: sum of 3 quarters · filed 2025-06-03 | $573.00K 20-F · filed 2025-06-03 | |
| 2022-09-30 | -$1.37M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-15 | $2.03M derived: sum of 2 quarters · filed 2023-11-15 | $1.87M 6-K · filed 2023-11-15 | -$438.00K derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-06-30 | $3.40M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | $3.24M 6-K · filed 2023-08-14 | $928.00K derived: sum of 3 quarters · filed 2024-08-29 | -$2.13M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-03-31 | -$158.00K 6-K · filed 2023-05-12 | $158.00K 6-K · filed 2022-05-13 | -$2.47M derived: sum of 2 quarters · filed 2024-08-29 | -$5.53M derived: sum of 3 quarters · filed 2024-08-29 | -$5.67M derived: sum of 4 quarters · filed 2024-08-29 |
| 2021-12-31 | -$2.31M derived: 20-F 12 month − 6-K/A 9 month · filed 2024-08-29 | -$5.37M derived: sum of 2 quarters · filed 2024-08-29 | -$5.51M derived: sum of 3 quarters · filed 2024-08-29 | -$2.78M 20-F · filed 2024-08-29 | |
| 2021-09-30 | -$3.06M derived: 6-K/A 9 month − 6-K 6 month · filed 2022-11-16 | -$3.20M derived: sum of 2 quarters · filed 2022-11-16 | -$469.00K 6-K/A · filed 2022-11-16 | -$2.22M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-06-30 | -$141.00K derived: 6-K 6 month − 6-K 3 month · filed 2022-08-15 | $2.59M 6-K · filed 2022-08-15 | $836.00K derived: sum of 3 quarters · filed 2023-05-02 | $5.43M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-03-31 | $2.73M 6-K · filed 2022-05-13 | -$2.73M 6-K · filed 2021-05-14 | $977.00K derived: sum of 2 quarters · filed 2023-05-02 | $5.58M derived: sum of 3 quarters · filed 2023-05-02 | $3.34M derived: sum of 4 quarters · filed 2023-05-02 |
| 2020-12-31 | -$1.75M derived: 20-F 12 month − 6-K 9 month · filed 2023-05-02 | $2.84M derived: sum of 2 quarters · filed 2023-05-02 | $609.00K derived: sum of 3 quarters · filed 2023-05-02 | -$1.63M 20-F · filed 2023-05-02 | |
| 2020-09-30 | $4.60M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-12 | $2.36M derived: sum of 2 quarters · filed 2021-11-12 | $126.00K 6-K · filed 2021-11-12 | -$1.78M derived: sum of 4 quarters · filed 2022-03-30 | |
| 2020-06-30 | -$2.23M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-13 | -$4.47M 6-K · filed 2021-08-13 | -$6.37M derived: sum of 3 quarters · filed 2022-03-30 | -$8.33M derived: sum of 4 quarters · filed 2022-03-30 | |
| 2020-03-31 | -$2.24M 6-K · filed 2021-05-14 | -$4.14M derived: sum of 2 quarters · filed 2022-03-30 | -$6.09M derived: sum of 3 quarters · filed 2022-03-30 | -$8.29M derived: sum of 4 quarters · filed 2022-03-30 | |
| 2019-12-31 | -$1.90M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-30 | -$3.86M derived: sum of 2 quarters · filed 2022-03-30 | -$6.05M derived: sum of 3 quarters · filed 2022-03-30 | -$2.71M 20-F · filed 2022-03-30 | |
| 2019-09-30 | -$1.96M derived: 6-K 9 month − 6-K 6 month · filed 2020-11-13 | -$4.15M derived: sum of 2 quarters · filed 2020-11-13 | -$805.00K 6-K · filed 2020-11-13 | $2.48M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-06-30 | -$2.20M derived: 6-K 6 month − 6-K 3 month · filed 2020-08-14 | $1.15M 6-K · filed 2020-08-14 | $4.44M derived: sum of 3 quarters · filed 2021-03-29 | $4.06M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-03-31 | $3.35M 6-K · filed 2020-05-14 | $6.63M derived: sum of 2 quarters · filed 2021-03-29 | $6.25M derived: sum of 3 quarters · filed 2021-03-29 | $10.44M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2018-12-31 | $3.29M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | $2.91M derived: sum of 2 quarters · filed 2021-03-29 | $7.10M derived: sum of 3 quarters · filed 2021-03-29 | $7.09M 20-F · filed 2021-03-29 | |
| 2018-09-30 | -$382.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-11-13 | $3.81M derived: sum of 2 quarters · filed 2019-11-13 | $3.81M 6-K · filed 2019-11-13 | $2.92M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-06-30 | $4.19M derived: 6-K 6 month − 6-K 3 month · filed 2019-08-14 | $4.19M 6-K · filed 2019-08-14 | $3.30M derived: sum of 3 quarters · filed 2020-03-30 | $3.77M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-03-31 | -$1.00K 6-K · filed 2019-05-15 | -$889.00K derived: sum of 2 quarters · filed 2020-03-30 | -$415.00K derived: sum of 3 quarters · filed 2020-03-30 | -$782.00K derived: sum of 4 quarters · filed 2020-03-30 | |
| 2017-12-31 | -$888.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | -$414.00K derived: sum of 2 quarters · filed 2020-03-30 | -$781.00K derived: sum of 3 quarters · filed 2020-03-30 | -$1.17M 20-F · filed 2020-03-30 | |
| 2017-09-30 | $474.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-13 | $107.00K derived: sum of 2 quarters · filed 2018-11-13 | -$279.00K 6-K · filed 2018-11-13 | ||
| 2017-06-30 | -$367.00K derived: 6-K 6 month − 6-K 3 month · filed 2018-08-13 | -$753.00K 6-K · filed 2018-08-13 | |||
| 2017-03-31 | -$386.00K 6-K · filed 2018-05-15 | ||||
| 2016-12-31 | $1.64M 20-F · filed 2019-03-29 | ||||
| 2015-12-31 | -$258.00K 20-F · filed 2018-03-30 |